Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Portuguese research shows Helicobacter pylori cancer risk:

This article was originally published in Clinica

Executive Summary

Individuals infected with certain strains of the Helicobacter pylori bacterium and who have specific genetic polymorphisms are more likely to develop stomach cancer, say US researchers. The 443-patient study, conducted at the University of Porto, Portugal, found that people with a high-activity version of the interleukin-1 beta gene who were infected with H Pylori with a particular variant of the vacA vacuolating cytotoxin had a nearly 90-fold increase in risk of stomach cancer. The findings appear in the Journal of the National Cancer Institute (November 20).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT069114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel